BSBR Borrow Cost Triples Before Q3 Results
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Borrowing costs for BSBR tripled almost overnight. The cost to borrow shot to 12.91% on October 22, up from 2.15% the day before, a move of 500% in a single session and the sharpest spike since a brief 13.97% reading on September 30.
That jump stands against an otherwise loosening lending picture. Availability at 190%, meaning nearly twice as many shares remain available to borrow as are currently lent out, and the borrow pool tightened sharply on October 20 and 21 before snapping back. Short interest itself has climbed 77% over the past month to roughly 8.2 million shares, though it pulled back 4% on October 22 after peaking mid-week. The pattern suggests episodic demand for borrows rather than a sustained structural short build. At 3.38 days to cover on the most recent official FINRA settlement, the position is not especially large in absolute terms.
The analyst community has moved steadily against the stock. JP Morgan downgraded to Neutral in late July, cutting its target to $6.00, and HSBC followed in September with a downgrade to Hold and a target of $6.20. UBS downgraded to Neutral in August. Three downgrades from Buy-equivalent ratings in three months represent a meaningful shift in the consensus. The mean analyst price target is $6.92 against a current price of $5.55, implying upside on paper, but that consensus reflects a period before the recent wave of cuts and should be read with caution. The PE multiple has drifted down to 6.86 and the price-to-book has fallen to just above 1.0, compressing roughly 4% over the past month as the stock has lost nearly 5%.
Insider activity adds a consistent signal on the other side. Net selling of around 388,000 shares over the past 90 days totalled approximately $2.2 million in value. Two executive vice presidents each sold 50,000 shares at $5.79 on September 22. None of the trades were under pre-arranged 10b5-1 plans. The selling is not dramatic in scale relative to the company's $20 billion market cap, but it is directionally consistent with the analyst downgrades.
The options market is not particularly exercised. The put/call ratio of 0.25 sits just below its 20-day average, close to the lowest end of its 52-week range, which stretches from 0.05 to 2.22. That puts options traders on the more complacent end of the spectrum rather than the defensive one, a contrast worth noting given the borrow cost spike.
The Q3 print on October 28 will test whether the bank can show any improvement in earnings momentum. EPS momentum scores rank in the 3rd percentile over 90 days and the 35th over 30 days, and the EPS surprise factor sits in the 15th percentile. The specific number to watch is net interest margin: the three recent analyst downgrades all centre on whether Brazilian rate dynamics are compressing the bank's spread income fast enough to justify a re-rating from what was, not long ago, a broadly Buy-rated name.
Stocks in this article
See the live data behind this article on ORTEX.
Open BSBR on ORTEX →How this article was generated
- Generated
- 25 Oct 2026, 04:16
- Data as of
- 25 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.